| DC Field | Value | Language |
|---|
| dc.contributor.author | Kokhan, V. S. | - |
| dc.contributor.author | Anokhin, P. K. | - |
| dc.contributor.author | Abaimov, D. A. | - |
| dc.contributor.author | Shamakina, I. Yu. | - |
| dc.contributor.author | Soldatov, V. O. | - |
| dc.contributor.author | Deykin, A. V. | - |
| dc.date.accessioned | 2025-05-15T07:21:44Z | - |
| dc.date.available | 2025-05-15T07:21:44Z | - |
| dc.date.issued | 2022 | - |
| dc.identifier.citation | Neurokinin-1 receptor antagonist rolapitant suppresses anxiety and alcohol intake produced by repeated withdrawal episodes / V.S. Kokhan, P.K. Anokhin, D. A. Abaimov [et al.] // FEBS Journal. - 2022. - Vol.289, №16.-P. 5021-5029. - Doi: 10.1111/febs.16400. - Refer.: p. 5027-5029. | ru |
| dc.identifier.uri | http://dspace.bsuedu.ru/handle/123456789/65194 | - |
| dc.description.abstract | Neurokinin-1 receptor (NK1r) antagonists have been shown to suppress operant self-administration of alcohol, voluntary alcohol consumption and stress-induced reinstatement of alcohol-seeking behaviour. Our findings suggest that rolapitant should be further investigated as a novel treatment option for relapse prevention in alcohol-dependent patients | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | alcohol consumption | ru |
| dc.subject | rolapitant | ru |
| dc.subject | anxiety | ru |
| dc.subject | neurokinin-1 receptor | ru |
| dc.subject | withdrawal | ru |
| dc.title | Neurokinin-1 receptor antagonist rolapitant suppresses anxiety and alcohol intake produced by repeated withdrawal episodes | ru |
| dc.type | Article | ru |
| Appears in Collections: | Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)
|
